Narrow Results Clear All
Search results for "Risk Managers"
Journal Article > Study
Meara E, Horwitz JR, Powell W, et al. N Engl J Med. 2016;375:44-53.
Growing rates of opioid misuse endanger public health. The impact of legal restrictions to limit high-risk prescribing and resultant adverse events is unclear. One recent study found that opioid-related adverse events were effectively reduced in states with stringent prescription drug monitoring programs compared to states without such regulations. However, this study examined data regarding Medicare beneficiaries with disabilities before and after adoption of controlled-substance laws and found no significant decrease in rates of nonfatal overdose, high opioid doses, or receipt of opioids from four or more prescribers. These results suggest that current regulatory policy may not be sufficient to address high-risk prescribing practices among Medicare beneficiaries with disabilities. More work is needed to develop effective strategies to treat chronic pain safely in this high-risk population. A WebM&M commentary described risks related to prescribing opioids for patients with chronic pain.
Journal Article > Commentary
Iatrogenic disease management: moderating medication errors and risks in a pharmacy benefit management environment.
Nair V, Salmon JW, Kaul AF. Dis Manage. 2007;10:337-346.
This article addresses the effectiveness of integrating medication error reduction efforts into disease management programs in a managed care organization.